Short Interest in First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Increases By 33.3%

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) was the target of a significant increase in short interest in the month of January. As of January 31st, there was short interest totalling 1,200 shares, an increase of 33.3% from the January 15th total of 900 shares. Based on an average daily volume of 2,900 shares, the short-interest ratio is presently 0.4 days.

First Trust Nasdaq Pharmaceuticals ETF Trading Down 1.4 %

Shares of FTXH traded down $0.38 during midday trading on Friday, reaching $27.25. 455 shares of the stock were exchanged, compared to its average volume of 3,332. The company’s 50 day moving average is $27.31 and its two-hundred day moving average is $28.15. First Trust Nasdaq Pharmaceuticals ETF has a 52 week low of $25.73 and a 52 week high of $29.72. The company has a market capitalization of $13.63 million, a P/E ratio of 15.98 and a beta of 0.70.

First Trust Nasdaq Pharmaceuticals ETF Increases Dividend

The business also recently declared a dividend, which was paid on Tuesday, December 31st. Shareholders of record on Friday, December 13th were issued a $0.1304 dividend. The ex-dividend date of this dividend was Friday, December 13th. This is a boost from First Trust Nasdaq Pharmaceuticals ETF’s previous dividend of $0.13.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the company. Ameritas Investment Partners Inc. boosted its stake in shares of First Trust Nasdaq Pharmaceuticals ETF by 13.0% in the fourth quarter. Ameritas Investment Partners Inc. now owns 14,173 shares of the company’s stock worth $382,000 after buying an additional 1,633 shares during the last quarter. Envestnet Asset Management Inc. boosted its holdings in First Trust Nasdaq Pharmaceuticals ETF by 17.0% during the fourth quarter. Envestnet Asset Management Inc. now owns 16,403 shares of the company’s stock worth $442,000 after buying an additional 2,384 shares in the last quarter. Finally, LPL Financial LLC grew its position in First Trust Nasdaq Pharmaceuticals ETF by 9.3% during the fourth quarter. LPL Financial LLC now owns 55,876 shares of the company’s stock valued at $1,507,000 after buying an additional 4,776 shares during the period.

First Trust Nasdaq Pharmaceuticals ETF Company Profile

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.